Verano Holdings (VRNO) Intangibles (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Intangibles of $564.6 million for Q1 2026, down 21.29% year-over-year from $717.3 million in Q1 2025, and down 2.51% quarter-over-quarter from $579.1 million in Q4 2025.
Verano Holdings (VRNO) Intangibles (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Intangibles for 6 consecutive years, with $564.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles fell 21.29% year-over-year to $564.6 million; the TTM figure through Mar 2026 stood at $564.6 million (down 21.29% YoY), while the FY2025 annual figure was $579.1 million, down 21.11% from the prior year.
- Intangibles eased to $564.6 million in Q1 2026 per VRNO's latest filing, from $579.1 million in the prior quarter.
- Across five years, Intangibles topped out at $1.3 billion in Q2 2022 and bottomed at $564.6 million in Q1 2026.
- Historically, Intangibles has averaged $967.2 million across 5 years, with a median of $1.1 billion in 2024.
- Annual changes were most pronounced in 2022 — Intangibles soared 176659.34% — and 2025, when it slumped 34.72%.
- Verano Holdings' Intangibles stood at $1.2 billion in 2022, then dropped by 8.01% to $1.1 billion in 2023, then plunged by 32.42% to $734.0 million in 2024, then retreated by 21.11% to $579.1 million in 2025, then retreated by 2.51% to $564.6 million in 2026.
- Business Quant data shows VRNO's Intangibles at $564.6 million in Q1 2026, $579.1 million in Q4 2025, and $683.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 1.12 Bn |
| 10 | Verano Holdings | 450.50 Mn | 365.31 Mn | 99.70 Mn | 550.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 550.12 Mn |
| Mar 31, 2026 | 564.58 Mn |
| Dec 31, 2025 | 579.09 Mn |
| Sep 30, 2025 | 683.77 Mn |
| Jun 30, 2025 | 700.52 Mn |
| Mar 31, 2025 | 717.26 Mn |
| Dec 31, 2024 | 734.01 Mn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 1.06 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.18 Bn |
| Sep 30, 2022 | 1.33 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Dec 31, 2021 | 1.38 Bn |
| Jun 30, 2021 | 760,000.00 |